Viking Global Investors Portfolio holdings
AUM
$34.6B
1-Year Return
30.14%
This Quarter Return
-3.75%
1 Year Return
+30.14%
3 Year Return
+120.76%
5 Year Return
+143.03%
10 Year Return
+428.26%
AUM
$36.5B
AUM Growth
+$3.48B
(+11%)
Cap. Flow
+$4.39B
Cap. Flow
% of AUM
12.05%
Top 10 Holdings %
Top 10 Hldgs %
38.65%
Holding
113
New
25
Increased
26
Reduced
33
Closed
17
Top Buys
| 1 |
Ginkgo Bioworks
DNA
|
+$3.93B |
| 2 |
Humana
HUM
|
+$941M |
| 3 |
McDonald's
MCD
|
+$721M |
| 4 |
Brookfield
BN
|
+$688M |
| 5 |
Parker-Hannifin
PH
|
+$681M |
Top Sells
| 1 |
Amazon
AMZN
|
+$891M |
| 2 |
Aon
AON
|
+$693M |
| 3 |
Palo Alto Networks
PANW
|
+$655M |
| 4 |
ServiceNow
NOW
|
+$574M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$474M |
Sector Composition
| 1 | Healthcare | 38.33% |
| 2 | Technology | 18.92% |
| 3 | Industrials | 11.99% |
| 4 | Consumer Discretionary | 11.25% |
| 5 | Financials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GTM
51
ZoomInfo Technologies
GTM
$3.72B
| $236M | 0.65% |
3,859,159
+1,477,885
| +62% | +$90.4M |
|
52
Canadian Pacific Kansas City
CP
$68.9B
| $224M | 0.62% |
+3,447,633
| New | +$224M |
|
53
Tenet Healthcare
THC
$17B
| $223M | 0.61% |
3,353,856
+1,074,674
| +47% | +$71.4M |
|
54
Labcorp
LH
$23.1B
| $223M | 0.61% |
921,592
-677,062
| -42% | -$164M |
|
55
Match Group
MTCH
$9.08B
| $214M | 0.59% |
1,365,007
-991,399
| -42% | -$156M |
|
56
Procept Biorobotics
PRCT
$2.07B
| $187M | 0.51% |
+4,907,892
| New | +$187M |
|
57
Ingersoll Rand
IR
$31.3B
| $184M | 0.5% |
3,641,009
-2,776,245
| -43% | -$140M |
|
|
INBX
58
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $177M | 0.48% |
5,305,866
| – | – |
|
59
Marsh & McLennan
MMC
$99.8B
| $175M | 0.48% |
1,156,185
-901,276
| -44% | -$136M |
|
60
Intellia Therapeutics
NTLA
$1.23B
| $172M | 0.47% |
1,279,531
+304,439
| +31% | +$40.8M |
|
|
CTLT
61
DELISTED
CATALENT, INC.
CTLT
| $155M | 0.42% |
1,163,034
+44,569
| +4% | +$5.93M |
|
62
Royalty Pharma
RPRX
$15.7B
| $150M | 0.41% |
4,140,508
+901,854
| +28% | +$32.6M |
|
63
Zentalis Pharmaceuticals
ZNTL
$107M
| $141M | 0.39% |
2,118,284
-281,000
| -12% | -$18.7M |
|
64
Acadia Healthcare
ACHC
$2.01B
| $134M | 0.37% |
2,102,758
+42,633
| +2% | +$2.72M |
|
65
HDFC Bank
HDB
$179B
| $123M | 0.34% |
+1,679,130
| New | +$123M |
|
66
PVH
PVH
$3.9B
| $119M | 0.33% |
1,161,695
+522,221
| +82% | +$53.7M |
|
|
KRTX
67
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $106M | 0.29% |
868,696
+46,231
| +6% | +$5.66M |
|
68
4D Molecular Therapeutics
FDMT
$318M
| $106M | 0.29% |
3,937,914
| – | – |
|
|
69
Thermo Fisher Scientific
TMO
$181B
| $104M | 0.29% |
182,237
-829,164
| -82% | -$474M |
|
70
AdaptHealth
AHCO
$1.26B
| $94.9M | 0.26% |
4,074,029
+977,601
| +32% | +$22.8M |
|
71
Align Technology
ALGN
$9.54B
| $74.2M | 0.2% |
111,570
-292,517
| -72% | -$195M |
|
72
Olaplex Holdings
OLPX
$947M
| $74M | 0.2% |
+3,022,372
| New | +$74M |
|
73
Rallybio
RLYB
$25.1M
| $73.7M | 0.2% |
+4,194,777
| New | +$73.7M |
|
74
Charles River Laboratories
CRL
$7.52B
| $73.2M | 0.2% |
177,403
-174,465
| -50% | -$72M |
|
75
Illumina
ILMN
$14.6B
| $63M | 0.17% |
+159,668
| New | +$63M |
|